RE:RE:Willow Biosciences Looks To Launch Biosynthesized THC In CanNot avoiding the CBD market, just navigating the compliance issues. Willow can produce a much cheaper, cleaner, and faster CBD product but the current law is restrictive.
The FDA approved Epidiolex (Cannabidiol) for GW Pharmaceuticals in 2018 who are looking to protect their market position while the use of CBD is classified as a controlled substance in the US.
This is one reason why Willow have pursued CBG as it will prove to be less problematic in a compliance sense than CBD products. CBG is also the precursor for CBD and THC. CBG may have similar properties to CBD and has not been classified as a controlled substance in the US.